Prognostic Value of Rb-82 PET Myocardial Perfusion Imaging

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01474577
First received: November 15, 2011
Last updated: May 29, 2014
Last verified: May 2014
  Purpose

The physician would like to see if nuclear cardiac stress tests can predict cardiac health. For example, if a patient has an abnormal stress test, is he or she more likely to have cardiac problems in the future?


Condition Intervention
Cardiac Health
Other: questionnaire

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective

Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • correlate scan findings with clinical outcomes [ Time Frame: 1 year ] [ Designated as safety issue: No ]
    Patients will complete one questionnaire over the phone.


Estimated Enrollment: 200
Study Start Date: November 2011
Estimated Study Completion Date: November 2015
Estimated Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
pts who have had Rb-82 PET myocardial perfusion imaging
Eligible patients will have had Rb-82 PET myocardial perfusion imaging at MSKCC, 2008 - 2011. Patients will complete one questionnaire over the phone.
Other: questionnaire
Patients will complete one questionnaire over the phone. We will ask patients to describe their cardiac history since Rb-82 PET (chest pain, shortness of breath, cardiac catheterization, and heart attack). This information will be correlated to the scan results and other relevant information in the patient's medical record.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patient with one or more 82Rb myocardial perfusion stress tests performed at MSKCC, 2008—2011.

Criteria

Inclusion Criteria:

  • Patient > or = to 18 years of age
  • Registered patient at MSKCC
  • Patient with one or more 82Rb myocardial perfusion stress tests performed at MSKCC, 2008—2011

Exclusion Criteria:

  • Patient is unwilling to participate
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01474577

Locations
United States, New York
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Investigators
Principal Investigator: Heiko Schöder, MD Memorial Sloan-Kettering Cancer Center
  More Information

Additional Information:
No publications provided

Responsible Party: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT01474577     History of Changes
Other Study ID Numbers: 11-150
Study First Received: November 15, 2011
Last Updated: May 29, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:
stress test
cardiac issues
Rb-82 PET Myocardial Perfusion Imaging
11-150
one or more 82Rb myocardial perfusion stress tests

ClinicalTrials.gov processed this record on August 26, 2014